Upgrade to SI Premium - Free Trial

Haemonetics (HAE)

77.40 -0.63 (0.81%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Haemonetics (HAE) PT Raised to $90 at Mizuho July 15, 2026 6:39 AM - StreetInsider U.S. MedTech stocks: Q2 earnings preview July 12, 2026 10:00 AM - StreetInsider Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026 July 8, 2026 4:05 PM - PR NewsWire Citi Adds Four Names to Catalyst Call List July 8, 2026 5:18 AM - StreetInsider BTIG Reiterates Buy Rating on Haemonetics (HAE) June 26, 2026 5:45 AM - StreetInsider Haemonetics (HAE) PT Raised to $85 at Mizuho June 15, 2026 6:38 AM - StreetInsider Form ARS HAEMONETICS CORP For: Mar 28 June 9, 2026 4:23 PM - SEC Filing Form DEFA14A HAEMONETICS CORP June 9, 2026 4:21 PM - SEC Filing Form DEF 14A HAEMONETICS CORP For: Mar 28 June 9, 2026 4:18 PM - SEC Filing Form 4 HAEMONETICS CORP For: Jun 05 Filed by: Maunsell Farris Maryanne June 8, 2026 4:19 PM - SEC Filing Form 4 HAEMONETICS CORP For: Jun 05 Filed by: Miller Laurie A. June 8, 2026 4:16 PM - SEC Filing Form 8-K HAEMONETICS CORP For: Jun 05 June 5, 2026 6:33 AM - SEC Filing Haemonetics restructures reporting segments from three to two June 5, 2026 6:30 AM - StreetInsider Haemonetics Updates Financial Reporting Segments June 5, 2026 6:30 AM - PR NewsWire Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference June 2, 2026 4:05 PM - PR NewsWire Form SD HAEMONETICS CORP May 28, 2026 5:01 PM - SEC Filing Haemonetics (HAE) PT Raised to $70 at Citi May 28, 2026 6:51 AM - StreetInsider BofA Securities Upgrades Haemonetics (HAE) to Buy May 22, 2026 6:05 AM - StreetInsider Form 10-K HAEMONETICS CORP For: Mar 28 May 20, 2026 6:32 AM - SEC Filing Form 4 HAEMONETICS CORP For: May 15 Filed by: Basil Michelle L May 19, 2026 5:38 PM - SEC Filing Form 4 HAEMONETICS CORP For: May 15 Filed by: Chan Frank May 19, 2026 5:37 PM - SEC Filing Form 4 HAEMONETICS CORP For: May 15 Filed by: DArecca James May 19, 2026 5:35 PM - SEC Filing Form 4 HAEMONETICS CORP For: May 15 Filed by: Maunsell Farris Maryanne May 19, 2026 5:33 PM - SEC Filing Form 4 HAEMONETICS CORP For: May 15 Filed by: Galvin Roy May 19, 2026 5:32 PM - SEC Filing Form 4 HAEMONETICS CORP For: May 15 Filed by: Miller Laurie A. May 19, 2026 5:30 PM - SEC Filing Form 4 HAEMONETICS CORP For: May 15 Filed by: Simon, Christopher May 19, 2026 5:28 PM - SEC Filing Form SCHEDULE 13G/A HAEMONETICS CORP Filed by: North Peak Capital Management, LLC May 13, 2026 10:40 AM - SEC Filing Haemonetics (HAE) PT Lowered to $67 at Baird May 8, 2026 7:57 AM - StreetInsider Haemonetics (HAE) Tops Q4 EPS by 2c May 7, 2026 6:41 AM - StreetInsider Form 8-K HAEMONETICS CORP For: May 07 May 7, 2026 6:08 AM - SEC Filing Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website May 7, 2026 6:00 AM - PR NewsWire Form 4 HAEMONETICS CORP For: May 01 Filed by: DArecca James May 5, 2026 4:25 PM - SEC Filing Haemonetics to Present at Bank of America 2026 Healthcare Conference May 5, 2026 6:00 AM - PR NewsWire Form 8-K HAEMONETICS CORP For: Apr 27 May 1, 2026 4:18 PM - SEC Filing Form SCHEDULE 13G HAEMONETICS CORP Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 30, 2026 10:29 AM - SEC Filing Form SCHEDULE 13G HAEMONETICS CORP Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC April 29, 2026 1:39 PM - SEC Filing New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures April 24, 2026 6:20 AM - PR NewsWire Full Article List